Turnover (€M) 2024-2025 2023-2024 Change Change at constant exchange rates 4th quarter 83.3 80.1 +4.0% +3.8% O/w Closures ...

PRISMAFLEX INTERNATIONAL - Increase in Q4 total sales by +10.9% - 2024-2025 annual revenue: EUR 54.9 million, up +6.1% - ...

THE BLOCKCHAIN GROUP - The Blockchain Group announces a convertible bond issuance of - EUR 12.1M to accelerate its Bitcoin ...

KLEA HOLDING (FR0013481835 – ALKLH), a group focused on the acquisition, development, and digitalization of companies across ...

AMOEBA - Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.

CCEP today hosts a Capital Markets Event in Manila for analysts and investors. Chair Sol Daurella, Chief Executive Damian Gammell and members of the executive leadership team will present our growth ...

FERMENTALG - The FDA's approval of Fermentalg's natural blue dye paves the way for a new generation of bio-based products in ...

Resignation of Ms. Rong Huang from her mandate as a director linked to BOE Proposal for the appointment of two new independent directors at the next Group Annual General Meeting Following the recent ...

Quarterly activity increased by +2.4% (+1.6% on a comparable basis) Strong growth in the Europe, Mediterranean, and Americas region (+5.0%), while the Africa and Asia-Pacific region declined (-4.0%) ...

Highest price paid (per ordinary share) USD 88.6800 GBP 68.0000 GBP 68.0000 GBP 68.0000 Lowest price paid (per ordinary share) USD 86.8300 GBP 66.2000 GBP 66.2000 GBP 66.2000 Volume weighted average ...

Resolution 24 is a standing item at each Annual General Meeting of the Company to enable CCEP to give effect to Resolutions 27 and 28. Therefore, a share repurchase cannot occur unless Resolution 24 ...